[1] |
LI Shixu, LI Linyun, WANG Xin, LI Ke, BIAN Hua.
Effects of Ginkgo biloba extract on renal injury in rats with experimental renal failure through miR-145/FOXO1 axis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 728-735.
|
[2] |
LIU Wenjing, WU Zhitao, PAN Guoyu.
Early dectection and prediction hepatotoxic risk in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 923-930.
|
[3] |
SONG Ruzheng, PENG Ying, WANG Guangji, SUN Jianguo.
Commonly used quantitative proteomics research techniques and their application in the study of pathogenesis of liver-derived diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 570-578.
|
[4] |
YI Hong, GU Bing, CHEN Yunian, LI Huanan.
Neutrophil extracellular traps and its role in gouty diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1167-1173.
|
[5] |
PENG Fusheng, HUANG Xiaohui, LI Peng, TANG Jian'er.
miR-34a inhibits proliferation of prostate cancer LNCaP cells by regulating androgen receptor gene
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 10-17.
|
[6] |
JIANG Bingbing.
Research progress on microRNAs in Huntington's disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 677-685.
|
[7] |
SHEN Lei, WANG Keke, YANG Jingke, ZHAO Juntao, MENG Xiangguang, YUAN Yiqiang.
Advances in drugs and genetic pharmacology for heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 343-349.
|
[8] |
ZHU Linjia, YUAN Shaofei, SHANGGUAN Zongxiao, CI Xiao, ZHAO Renguo, LI Yuping.
Ultrasound-microbubbles mediated microRNA-449a inhibits lung cancer cell growth via the regulation of Notch1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1385-1393.
|
[9] |
HAN Chenyang, YANG Yi, LI Wenyang, WANG Jin, GUO Li.
Inhibitory effect of MicroRNA-136 targeting CD163 on the polarization of CD68+CD163+M2 macrophages
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(1): 1-8.
|
[10] |
SHEN Binbin, ZHOU Jun, LI Liang, LU Ning, YAO Ming.
Long non-coding RNA TSIX regulates the proliferation of human pancreatic cancer cells by targeting miR-384
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 621-626.
|
[11] |
LIU lei, LI Yixiao, WAN Bo, ZENG Qing.
miR-200c induces resistance to doxorubicin through the Wnt/beta-catenin signaling pathway in bladder cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 510-516.
|
[12] |
XU Ming, CUI Peng, YE Min, NI Xiong, WANG Tingfeng, MIN Zhijun.
Insights into tumor suppression mechanism of miRNA-101 in medullary thyroid carcinoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 524-530.
|
[13] |
ZENG Zhenhua, LIU Jianxin, CAO Chunya, WU Weihua.
Screening and bioinformatics analysis of differential microRNA in nitroglycerin-tolerant rat aorta
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1081-1087.
|
[14] |
LIU Li, GUO Chen-xian, PENG Jin-fu, HUANG Jie, YANG Guo-ping.
Development of microRNA-dependment control of drug transporter
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1064-1068.
|
[15] |
LI Zheng, XIANG Kai-ming, PENG Shu-ping, LI Gui-yuan.
Basic research of microRNA-34 for cancer therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 67-73.
|